Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres
Respirology2015Vol. 21(2), pp. 329–337
Citations Over TimeTop 10% of 2015 papers
Daniel J. Smith, Kay A. Ramsay, Stephanie T. Yerkovich, David W. Reid, Claire Wainwright, Keith Grimwood, Scott C. Bell, Timothy J. Kidd
Abstract
Increased treatment intensity in paediatric centres and the Australian state where treatment was received are both associated with greater risk of MARPA, but not worse clinical outcomes.
Related Papers
- → 113 Clinical and immunodulatory effects of once weekly azithromycin treatment in Cystic Fibrosis patients chronically infected with Pseudomonas aeruginosa(2006)12 cited
- → Use of azithromycin in cystic fibrosis patients not infected with Pseudomonas aeruginosa(2008)4 cited
- [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].(2006)
- → 57 Azithromycin influence on biofilm formation of Pseudomonas aeruginosa isolates from children with cystic fibrosis(2012)
- → 80 Long term effects of azithromycin maintenance treatment on lung function in pediatric cystic fibrosis patients chronically infected with Pseudomonas aeruginosa(2013)